Bavarian Nordic

About:

Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.

Website: http://www.bavarian-nordic.com

Twitter/X: bavariannordic

Top Investors: European Investment Bank, National Institutes of Health

Description:

Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.

Total Funding Amount:

$329M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Kvistgaard, Hovedstaden, Denmark

Founded Date:

1994-01-01

Contact Email:

info(AT)bavarian-nordic.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2021-10-03

IPO Status:

Public

© 2025 bioDAO.ai